mRNA Vaccine May Extend High-Risk Melanoma Remission

“An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, the pharmaceutical companies Moderna and Merck announced Wednesday. For decades, cancer vaccines have been one of the most tantalizing ideas in cancer treatment — offering the hope of harnessing a person’s own immune system to attack tumors… In the late-stage trial of […] The post mRNA Vaccine May Extend High-Risk Melanoma Remission appeared first on Human Progress.